Moshkevich Solomon 4

What Happened

• Solomon Moshkevich, President (Clinical Diagnostics) of Natera, received an award of 1,774 Restricted Stock Units (RSUs) on 2026-03-09 (RSUs were fully vested at issuance) and sold 915 shares in an open-market sale on 2026-03-10 at $204.13 per share for total proceeds of $186,781. The RSUs represent a contingent right to receive one share per RSU.

Key Details

• Transactions reported: Award/Grant (A) — 1,774 RSUs on 2026-03-09; Sale (S) — 915 shares on 2026-03-10 at $204.13 ($186,781 proceeds).
• The sale was effected to satisfy tax withholding and remittance obligations in connection with the vesting of the RSUs.
• The sale was made pursuant to a written instruction intended to satisfy the affirmative defense conditions of a Rule 10b5-1(c) plan as described in the Reporting Person's Stock Unit Agreement (granted 2026-03-09).
• Filing: Form 4 filed 2026-03-11 (reporting period begins 2026-03-09); filing appears timely under Form 4 reporting rules.
• Shares owned after the transactions: not specified in the provided filing details.

Context

• This transaction combines a grant of fully vested RSUs and a contemporaneous sale to cover tax obligations — a common administrative sale rather than a directional buy/sell signal. The RSU award increases potential future shares (one share per RSU) while the sale reduced the immediate share position to cover taxes.